Literature DB >> 20652807

99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.

David R Okada1, Zhonglin Liu, Gerald Johnson, Delia Beju, Ban An Khaw, Robert D Okada.   

Abstract

PURPOSE: (99m)Tc-glucarate is an infarct-avid imaging agent. However, patients may have mixtures of normal, irreversibly injured, stunned, and hibernating myocardium. The purposes were to determine (99m)Tc-glucarate uptake and clearance kinetics in these four conditions, and its ability to determine the extent of injury.
METHODS: Twenty-two perfused rat hearts were studied: controls (n = 5), stunned (n = 5; 20-min no-flow followed by 5-min reflow), hibernating (n = 6; 120-min low flow at 4 ml/min), and ischemic-reperfused (n = 6; 120-min no-flow followed by reflow). (99m)Tc-glucarate was then infused. Tracer activity was monitored using a NaI scintillation detector and a multichannel analyzer. Creatine kinase, electron microscopy, and triphenyltetrazolium chloride determined viability.
RESULTS: (99m)Tc-glucarate 10-min myocardial uptake was significantly greater in ischemic-reperfused (2.50 +/- 0.09) (cpm, SEM) than in control (1.74 +/- 0.07), stunned (1.68 +/- 0.11), and hibernating (1.59 +/- 0.11) (p < 0.05). Tracer retention curves for ischemic-reperfused were elevated at all time points as compared with the other groups. (99m)Tc-glucarate 60-min myocardial uptake was significantly greater in ischemic-reperfused (7.60 +/- 0.63) than in control (1.98 +/- 0.15), stunned (1.79 +/- 0.08), and hibernating (2.33 +/- 0.15) (p < 0.05). The 60-min well-counted tracer activity ratio of ischemic-reperfused to control was 9:1 and corroborated the NaI detector results. Creatine kinase, triphenyltetrazolium chloride, and electron microscopy all demonstrated significantly greater injury in ischemic-reperfused compared to the other groups. An excellent correlation was observed between viability markers and tracer activity (r = 0.99 triphenyltetrazolium chloride; r = 0.90 creatine kinase).
CONCLUSION: (99m)Tc-glucarate activity continually and progressively increased in irreversibly injured myocardium. (99m)Tc-glucarate uptake was strongly correlated with myocardial necrosis as determined by three independent assessments of viability. There were minimal and similar (99m)Tc-glucarate uptakes in control, stunned, and hibernating myocardium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652807     DOI: 10.1007/s00259-010-1495-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  14 in total

1.  Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment.

Authors:  B A Khaw; A Nakazawa; S M O'Donnell; K Y Pak; J Narula
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

2.  Histochemical and fluorescent techniques for detection of early myocardial ischemia following experimental coronary artery occlusion: a comparative and quantitative study.

Authors:  P Chopra; U Sabherwal
Journal:  Angiology       Date:  1988-02       Impact factor: 3.619

3.  Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.

Authors:  D R Okada; G Johnson; Z Liu; S D Hocherman; B A Khaw; K Y Pak; R D Okada
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

4.  Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

Authors:  W R Ford; A S Clanachan; C R Hiley; B I Jugdutt
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand.

Authors:  L L Johnson; L Schofield; P Mastrofrancesco; T Donahay; A Farb; B A Khaw
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

6.  (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.

Authors:  Gerald Johnson; Christine C Okada; Sonia D Hocherman; Zhonglin Liu; Curtis Hart; Ban-An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-20       Impact factor: 9.236

7.  Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.

Authors:  David R Okada; Gerald Johnson; Zhonglin Liu; Sonia D Hocherman; Ban-An Khaw; Robert D Okada
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

8.  Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium.

Authors:  H Yaoita; A J Fischman; R Wilkinson; B A Khaw; M Juweid; H W Strauss
Journal:  J Nucl Med       Date:  1993-08       Impact factor: 10.057

9.  Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats.

Authors:  H Ohtani; R J Callahan; B A Khaw; A J Fishman; R A Wilkinson; H W Strauss
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

10.  Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid.

Authors:  C Orlandi; P D Crane; D S Edwards; S H Platts; L Bernard; J Lazewatsky; M J Thoolen
Journal:  J Nucl Med       Date:  1991-02       Impact factor: 10.057

View more
  4 in total

1.  Assessment of myocardial viability with delayed-enhancement MRI in coronary artery disease: A correlative study with coronary artery stenosis using digital subtraction angiography.

Authors:  Xinxiang Zhao; Yanglin Zhang; Yong Sun; Lin Sun; Renhui Cai
Journal:  Exp Ther Med       Date:  2016-08-12       Impact factor: 2.447

2.  Cardiac molecular pathways influenced by doxorubicin treatment in mice.

Authors:  Ben F Bulten; Martina Sollini; Roberto Boni; Katrin Massri; Lioe-Fee de Geus-Oei; Hanneke W M van Laarhoven; Riemer H J A Slart; Paola A Erba
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

Review 3.  Untiring Pursuit for Glucarate-Based Molecular Imaging Probes.

Authors:  Dongjian Zhang; Qiaomei Jin; Meng Gao; Cuihua Jiang; Yicheng Ni; Jian Zhang
Journal:  Mol Imaging Biol       Date:  2020-11-18       Impact factor: 3.488

4.  (99m)Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: from bench to the bed side.

Authors:  Partha S Choudhury; E Savio; K K Solanki; O Alonso; A Gupta; J P Gambini; Dinesh Doval; P Sharma; M Dondi
Journal:  World J Nucl Med       Date:  2012-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.